• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

再次切除轻度和中度不典型痣的效用:回顾性分析。

The utility of re-excising mildly and moderately dysplastic nevi: a retrospective analysis.

机构信息

Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.

Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts.

出版信息

J Am Acad Dermatol. 2014 Dec;71(6):1071-6. doi: 10.1016/j.jaad.2014.08.025. Epub 2014 Sep 26.

DOI:10.1016/j.jaad.2014.08.025
PMID:25262175
Abstract

BACKGROUND

The management of dysplastic nevi (DN) is a highly debated and controversial topic within the dermatology community. Clinicians agree that margin-positive severely DN should be removed with a surgical margin, however, there is disagreement surrounding the appropriate management of margin-positive mildly and moderately DN.

OBJECTIVE

We sought to evaluate the utility of re-excising margin-positive mildly and moderately DN.

METHODS

A retrospective chart review was conducted on all adult patients given the diagnosis of a biopsy-proven DN from 2010 through 2011. The primary outcomes were defined as the presence of melanocytic residuum in re-excisional specimens and a clinically significant change in diagnosis.

RESULTS

A total of 1809 mildly and moderately DN were diagnosed from 2010 through 2011. In all, 765 (42.3%) of these lesions were found to have positive surgical margins during biopsy, and 495 (64.7) of the 765 lesions were subsequently re-excised. Melanocytic residuum was present in 18.2% of re-excisional specimens. Re-excision resulted in a clinically significant alteration of the diagnosis in only 1 case (0.2%).

LIMITATIONS

Limitations include retrospective design and inability to assess for malignant transformation given limited follow-up.

CONCLUSIONS

Re-excising mildly and moderately DN results in a low histopathological yield and rarely results in a clinically significant change in diagnosis. As such, clinical monitoring of margin-positive lesions may be warranted.

摘要

背景

在皮肤科领域,对发育不良痣(DN)的管理是一个备受争议的话题。临床医生一致认为,边缘阳性的重度 DN 应通过手术切除边缘,但对于边缘阳性的轻度和中度 DN 的适当处理存在分歧。

目的

我们旨在评估再次切除边缘阳性的轻度和中度 DN 的效用。

方法

对 2010 年至 2011 年所有被诊断为活检证实的 DN 的成年患者进行回顾性图表审查。主要结果定义为在再次切除标本中存在黑色素残留物和诊断的临床显著变化。

结果

2010 年至 2011 年共诊断出 1809 例轻度和中度 DN。所有这些病变中,765 例(42.3%)在活检时发现有阳性手术边缘,其中 495 例(64.7%)随后被再次切除。再次切除标本中存在黑色素残留物的比例为 18.2%。仅在 1 例(0.2%)中,再次切除导致诊断发生临床显著改变。

局限性

局限性包括回顾性设计以及由于随访时间有限而无法评估恶性转化。

结论

再次切除轻度和中度 DN 的组织病理学产量较低,很少导致诊断的临床显著改变。因此,可能需要对边缘阳性病变进行临床监测。

相似文献

1
The utility of re-excising mildly and moderately dysplastic nevi: a retrospective analysis.再次切除轻度和中度不典型痣的效用:回顾性分析。
J Am Acad Dermatol. 2014 Dec;71(6):1071-6. doi: 10.1016/j.jaad.2014.08.025. Epub 2014 Sep 26.
2
Reexamining the Threshold for Reexcision of Histologically Transected Dysplastic Nevi.重新审视组织学上切缘阳性的发育不良性痣再次切除的阈值。
JAMA Dermatol. 2016 Dec 1;152(12):1327-1334. doi: 10.1001/jamadermatol.2016.2869.
3
Margin comments in dermatopathology reports on dysplastic nevi influence re-excision rates.皮肤科病理报告中关于发育不良痣的边缘注释会影响再次切除率。
J Am Acad Dermatol. 2013 Nov;69(5):687-692. doi: 10.1016/j.jaad.2013.06.026. Epub 2013 Aug 6.
4
Atypical (dysplastic) nevi: outcomes of surgical excision and association with melanoma.非典型(发育不良)痣:手术切除的结果及与黑色素瘤的关系。
JAMA Dermatol. 2013 Aug;149(8):928-34. doi: 10.1001/jamadermatol.2013.4440.
5
Outcomes of biopsies and excisions of dysplastic acral nevi: a study of 187 lesions.肢端发育不良性黑素细胞痣的活检和切除术的结果:187 例病变的研究。
Dermatol Surg. 2014 Apr;40(4):455-9. doi: 10.1111/dsu.12448. Epub 2014 Jan 23.
6
A prospective study evaluating the utility of a 2-mm biopsy margin for complete removal of histologically atypical (dysplastic) nevi.一项前瞻性研究评估了 2 毫米活检边缘在完全切除组织学不典型(发育不良)痣中的作用。
J Am Acad Dermatol. 2017 Dec;77(6):1096-1099. doi: 10.1016/j.jaad.2017.07.016. Epub 2017 Oct 2.
7
A nongrading histologic approach to Clark (dysplastic) nevi: A potential to decrease the excision rate.Clark(发育不良)痣的非分级组织学方法:降低切除率的潜力。
J Am Acad Dermatol. 2016 Jan;74(1):68-74. doi: 10.1016/j.jaad.2015.09.030. Epub 2015 Nov 6.
8
Addressing the knowledge gap in clinical recommendations for management and complete excision of clinically atypical nevi/dysplastic nevi: Pigmented Lesion Subcommittee consensus statement.解决临床推荐管理和完整切除临床非典型痣/发育不良痣方面知识差距的问题:色素病变小组委员会共识声明。
JAMA Dermatol. 2015 Feb;151(2):212-8. doi: 10.1001/jamadermatol.2014.2694.
9
Dysplastic nevi with severe atypia: Long-term outcomes in patients with and without re-excision.具有重度异型性的发育不良痣:行与不行再次切除术患者的长期结局。
J Am Acad Dermatol. 2017 Feb;76(2):244-249. doi: 10.1016/j.jaad.2016.08.054. Epub 2016 Nov 9.
10
Histologic outcomes of excised moderate and severe dysplastic nevi.切除的中度和重度发育不良痣的组织学结果。
Dermatol Surg. 2014 Jan;40(1):40-5. doi: 10.1111/dsu.12391. Epub 2013 Dec 10.

引用本文的文献

1
Nevi and Melanoma.痣和黑素瘤。
Hematol Oncol Clin North Am. 2024 Oct;38(5):939-952. doi: 10.1016/j.hoc.2024.05.005. Epub 2024 Jun 15.
2
Novel Non-Invasive Quantification and Imaging of Eumelanin and DHICA Subunit in Skin Lesions by Raman Spectroscopy and MCR Algorithm: Improving Dysplastic Nevi Diagnosis.通过拉曼光谱和MCR算法对皮肤病变中真黑素和DHICA亚基进行新型非侵入性定量与成像:改善发育异常痣的诊断
Cancers (Basel). 2022 Feb 18;14(4):1056. doi: 10.3390/cancers14041056.
3
Risk Factors and Predictors of Survival Among Patients with Amelanotic Melanoma Compared to Melanotic Melanoma in the National Cancer Database.
与全国癌症数据库中黑色素瘤患者相比,无色素性黑色素瘤患者生存的危险因素及预测因素
J Clin Aesthet Dermatol. 2021 Dec;14(12):36-43.
4
Predictive Value of Positive Margins in Diagnostic Biopsies of Dysplastic Nevi.发育异常痣诊断性活检中切缘阳性的预测价值
Dermatol Res Pract. 2020 Jan 29;2020:6716145. doi: 10.1155/2020/6716145. eCollection 2020.
5
Economic Analysis of a Noninvasive Molecular Pathologic Assay for Pigmented Skin Lesions.色素沉着性皮肤病变无创分子病理检测的经济分析
JAMA Dermatol. 2018 Sep 1;154(9):1025-1031. doi: 10.1001/jamadermatol.2018.1764.
6
Variation among pathologists' treatment suggestions for melanocytic lesions: A survey of pathologists.病理学家对黑素细胞性病变的治疗建议差异:一项病理学家调查
J Am Acad Dermatol. 2017 Jan;76(1):121-128. doi: 10.1016/j.jaad.2016.07.029. Epub 2016 Sep 28.